HealthcareServices

Cross-Species Organ Transplantation Market Performance Outlook 2026–2030: Revenue to Hit $22.65 Billion at 8.2% CAGR

February 23, 2026February 24, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cross-species organ transplantation market from 2026–2035 with trusted insights from The Business Research Company

What level of CAGR-driven expansion is anticipated in the Cross-Species Organ Transplantation Market between 2026 and 2030?

The cross-species organ transplantation market has experienced robust growth in recent years. This market is expected to expand from $15.2 billion in 2025 to $16.5 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. In the past, this expansion has been primarily fueled by the shortage of human donor organs, early-stage xenotransplant research initiatives, advancements in genetic engineering tools, preclinical validation of animal-derived organs, and increasing transplant waiting lists.

The cross-species organ transplantation market is anticipated to experience robust expansion over the coming years, with its size projected to reach $22.65 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. This growth during the forecast period is primarily driven by heightened clinical trial activity in xenotransplantation, increased investment in gene-edited animal models, strengthened collaboration between biotechnology firms and transplant centers, ongoing advancements in immunosuppressive therapies, and the development of more extensive regulatory frameworks for xenotransplants.

Significant trends expected during the forecast period encompass further advancements in genetically engineered donor organs, a heightened focus on strategies to mitigate immune rejection, the expansion of organ preservation and perfusion technologies, an increase in investment dedicated to translational xenotransplant research, and the strengthening of both regulatory and ethical oversight.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27267&type=smp

What Drivers Are Affecting Demand-Supply Dynamics In The Cross-Species Organ Transplantation Market?

The increasing focus on genetic engineering is anticipated to drive the expansion of the cross-species organ transplantation market in the future. Genetic engineering involves the intentional alteration of an organism’s DNA through biotechnological methods to insert, delete, or modify particular genes. The surge in genetic engineering stems from the critical requirement to overcome organ scarcity by developing animal organs with enhanced compatibility for human transplants. This field aids the advancement of cross-species organ transplantation by allowing animal organs to be altered, thereby diminishing immune rejection and rendering them viable for human transplants. As an illustration, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific body, reported in July 2023 that 247 gene therapies were in Phase II by the close of the first quarter of 2023, a figure that climbed by 5% to 260 by the end of the second quarter. Consequently, the expanding adoption of genetic engineering is fueling the development of the cross-species organ transplantation market.

What Segments Are Included Within The Cross-Species Organ Transplantation Market?

The cross-species organ transplantation market covered in this report is segmented –

1) By Product Type: Organ Preservation Solution, Transplant Diagnostics, Xeno Products, Other Product Types

2) By Application: Kidney, Heart, Liver, Lung, Other Applications

3) By End-User: Transplant Centers, Hospitals, Other End-Users

Subsegments:

1) By Organ Preservation Solution: Hypothermic Machine Perfusion (HMP) Solutions, Normothermic Machine Perfusion (NMP) Solutions, Static Cold Storage (SCS) Solutions, Oxygenated Perfusion Solutions

2) By Transplant Diagnostics: Histocompatibility Testing, Crossmatching Tests, Molecular Typing (DNA-based Testing), Immunological Monitoring Assays

3) By Xeno Products: Genetically Engineered Donor Organs, Decellularized Organ Scaffolds, Xenogeneic Cellular Therapies, Immunosuppressive Regimens For Xenotransplants

4) By Other Product Types: Organ Transport Devices, Organ Recovery and Preservation Equipment, Surgical Instruments For Transplantation, Post-Transplant Monitoring Devices

What Trends Are Expected To Impact The Competitive Landscape Of The Cross-Species Organ Transplantation Market?

Major companies operating in the cross-species organ transplantation market are concentrating on establishing strategic partnerships to streamline the regulatory approval process for xenotransplantation solutions. Such an alliance enables companies to collaborate towards common goals by utilizing their respective strengths and resources, with the aim of fostering growth, innovation, and competitiveness without merging. A prime illustration occurred in February 2025 when United Therapeutics, a US-based biotechnology company, teamed up with eGenesis, a US-based pharmaceutical company, to commence clinical trials for pig kidney (xenotransplant) transplants in human recipients. This endeavor, which secured approval from the U.S. Food and Drug Administration (FDA) for transplanting genetically modified pig kidneys into patients with kidney failure, is designed to address the pressing shortage of donor kidneys by potentially offering a new, sustainable source of organs for individuals in need.

Who Are The Top-Performing Companies In The Cross-Species Organ Transplantation Market In Recent Years?

Major companies operating in the cross-species organ transplantation market are Novartis AG, Optipharm Co Ltd, Astellas Pharma Inc., United Therapeutics Corporation, TransMedics Group Inc., Artivion Inc., eGenesis Inc., Organ Recovery Systems Inc., OrganOX Ltd, Paragonix Technologies Inc., Qihan Biotech, PorMedTec Co., XenoTheraputics Inc., Makana Therapeutics Inc., Preservation Solutions Inc., Nzeno Ltd, Infigen Inc., Revivicor Inc., XVIVO Perfusion AB, Bridge To Life Ltd, Transplant Genomics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cross-species-organ-transplantation-global-market-report

Which Region Currently Holds The Largest Share Of The Cross-Species Organ Transplantation Market?

North America was the largest region in the cross-species organ transplantation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cross-species organ transplantation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cross-Species Organ Transplantation Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27267&type=smp

Browse Through More Reports Similar to the Global Cross-Species Organ Transplantation Market 2026, By The Business Research Company

Industrial Laser System Market Report 2026

https://www.thebusinessresearchcompany.com/report/industrial-laser-system-global-market-report

Construction Lasers Market Report 2026

https://www.thebusinessresearchcompany.com/report/construction-lasers-global-market-report

Laser Welding Machine Market Report 2026

https://www.thebusinessresearchcompany.com/report/laser-welding-machine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795